| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Assay identifies biomarker of autoimmune encephalitis subtype
Answers from the Lab
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' GABA-A receptor antibody assay aids diagnosis of this serious but treatable condition.
"The disease associated with the GABA-A receptor antibody is very immunotherapy-responsive, if treated early," Dr. McKeon says. However, few reliable testing options are available.
Mayo Clinic Laboratories' new cell-based GABA-A receptor antibody assay doesn't require reflex testing.
"We have a high level of confidence in this testing method," Dr. McKeon says. "It's an opportunity for doctors to be able to diagnose and confirm GABA-A receptor encephalitis, particularly in pediatric patients."
The GABA-A receptor antibody test is recommended — in conjunction with other autoimmune neurology profiles— for specific patients. "The phenotype of note is encephalopathy with seizures," Dr. McKeon says. "Patients also typically have multifocal large cerebral temporal and extra-temporal T2 signal abnormalities without enhancement. If you see patients with that, you should definitely work in GABA-A."
The assay is being launched as a standalone test to accommodate clients' IT systems while enhancing patient care.
Listen to learn more about Mayo Clinic Laboratories' GABA-A receptor antibody assay.
Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
